![]() |
市場調查報告書
商品編碼
1957300
實驗室及人體組織市場-全球產業規模、佔有率、趨勢、機會、預測:按產品、應用、最終用戶、地區及競爭對手分類,2021-2031年Laboratory Robotics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球勞動機器人市場預計將從 2025 年的 31 億美元成長到 2031 年的 48.4 億美元,複合年成長率為 7.71%。
此領域涵蓋用於臨床診斷和生命科學研究中執行重複性功能的機械和自動化系統,例如液體分裝、樣品處理和微孔板操作。主要成長要素包括藥物研發中對高通量篩檢日益成長的需求,以及減少複雜分析過程中人為錯誤的必要性。此外,熟練技術人員的長期短缺也加速了這些技術的應用,以確保操作的一致性和效率。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 31億美元 |
| 市場規模:2031年 | 48.4億美元 |
| 複合年成長率:2026-2031年 | 7.71% |
| 成長最快的細分市場 | 自動化液體處理機器人 |
| 最大的市場 | 北美洲 |
儘管存在這些優勢,但由於初始部署需要大量資金以及將這些系統整合到現有基礎設施中存在許多困難,市場仍面臨重大挑戰。根據國際機器人聯合會的數據,該產業正經歷著向自動化方向的重大轉變,預計到2024年,醫療檢測和診斷機器人的銷售將激增610%。雖然這一成長凸顯了該領域自動化的迫切性,但小型機構的採用仍然受到資金和技術限制的阻礙。
透過流程自動化解決技術純熟勞工短缺問題的迫切性是檢查室機器人市場的主要驅動力。慢性病發病率的上升導致檢測數量不斷增加,造成工作量與人力供應之間存在巨大缺口。人才難尋和人員流動率高加劇了這個問題。自動化透過處理勞動密集和重複性任務來減輕這一負擔,使有限的人員能夠專注於複雜的分析,並有助於防止職業倦怠。根據美國臨床病理學會於2025年10月發布的《2024年職缺調查》,病理科的職缺率高達28.5%,凸顯了嚴重的員工短缺問題,因此需要採用機器人解決方案來維持檢測量。
同時,對高通量檢測成本效益和擴充性的追求正推動該領域的大規模投資。臨床實驗室和生命科學公司正在採用自動化系統來提升其研發和生產能力,同時又不增加營運成本。在許多情況下,這是透過對傳統工作流程進行現代化改造以滿足全球醫療保健需求來實現的。例如,賽默飛世爾科技公司於2025年4月宣布了一項計劃,將在四年內投資20億美元,以加強其在美國的製造和檢測服務部門。國際機器人聯合會(IFR)發布的《2025年報告》也印證了這一行業趨勢,該報告指出,醫療機器人的銷量在上年度成長了91%,達到約16700台。
全球勞動機器人市場面臨的主要障礙之一是實施所需的巨額前期資本投入。部署機械臂和流體處理平台等先進自動化系統所需的資金往往超出學術Start-Ups、獨立臨床檢查室和小規模研究機構的預算。這種經濟差距造成了市場兩極化,只有資金雄厚的製藥公司才能充分利用自動化技術,迫使小規模的機構依賴人工流程。此外,將這些複雜的設備整合到現有基礎設施中成本高昂,且需要專業技術,進一步加劇了挑戰。
這些財務障礙的嚴重性體現在越來越多採用替代資金籌措模式以減少資本支出。 2024年,國際機器人聯合會報告稱,全球採用機器人即服務(RaaS)合約運作的專業服務機器人部署量成長了31%。這種基於訂閱和租賃的部署方式的成長表明,預算限制正在阻礙自動化市場相當一部分企業的資本支出。簡而言之,儘管對效率的營運需求仍然強勁,但傳統的採購模式仍然阻礙著資金受限的產業領域更廣泛地採用自動化技術。
透過將人工智慧整合到預測性工作流程中,實驗室操作正從被動執行轉變為主動最佳化。除了自動化諸如微孔板轉移和液體處理等重複性任務外,先進的演算法還能即時評估實驗參數、預測設備故障、識別數據異常,並在工作流程完成前最佳化檢測方案。這種向數據驅動的智慧生態系統的轉變,使實驗室能夠減少昂貴試劑的浪費,並縮短發現的時間。根據皮斯托亞聯盟於2024年9月發布的《2024年未來實驗室全球調查》,目前有68%的生命科學專業人員正在使用人工智慧和機器學習,這一比例較上年顯著成長,顯示實驗室越來越重視資料準備工作。
同時,自動化解決方案在次世代定序和基因組學領域的拓展,正顯著刺激實驗室市場,以滿足精準醫療的複雜需求。要實現這些精細基因組工作流程的自動化,需要高精度機器人來處理微量昂貴的生物樣本,並防止交叉污染——這是傳統工業自動化無法滿足的要求。這導致對專用生物醫學機器人系統的訂單激增,美國自動化協會(Association for Advancing Automation)在2025年2月發布的報告中也強調了這一趨勢。報告顯示,2024年製藥、生命科學和生物醫學領域的機器人訂單成長了46%,超過了傳統工業領域的成長速度。
The Global Laboratory Robotics Market is projected to expand from USD 3.10 Billion in 2025 to USD 4.84 Billion by 2031, registering a CAGR of 7.71%. This sector comprises mechanical devices and automated systems utilized in clinical diagnostics and life science research to execute repetitive functions like liquid dispensing, sample handling, and plate manipulation. Key growth drivers include the rising demand for high-throughput screening in drug discovery and the imperative to reduce human error in intricate analytical processes, while a persistent shortage of skilled technicians further accelerates the adoption of these technologies to ensure operational consistency and efficiency.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.10 Billion |
| Market Size 2031 | USD 4.84 Billion |
| CAGR 2026-2031 | 7.71% |
| Fastest Growing Segment | Automated Liquid Handling Robots |
| Largest Market | North America |
Despite these advantages, the market faces significant hurdles due to the substantial capital required for initial implementation and the difficulties associated with integrating these systems into existing infrastructure. Data from the International Federation of Robotics indicates a massive industry pivot toward automation, noting that sales of robots for medical laboratory analysis and diagnostics surged by 610 percent in 2024. While this increase underscores the sector's urgency to automate, financial and technical constraints continue to hinder adoption among smaller institutions.
Market Driver
The urgent need to address skilled labor deficits through process automation acts as a major catalyst for the laboratory robotics market. Rising chronic disease prevalence has increased testing volumes, creating a significant disparity between workload requirements and the available workforce, a problem worsened by recruitment struggles and high retirement rates. Automation alleviates this pressure by handling labor-intensive, repetitive tasks, enabling limited personnel to concentrate on complex analysis and mitigating burnout. According to the American Society for Clinical Pathology's '2024 Vacancy Survey', released in October 2025, anatomic pathology departments experienced a substantial vacancy rate of 28.5%, highlighting the critical staffing shortages that demand robotic solutions to sustain throughput.
Simultaneously, the drive for cost efficiency and operational scalability in mass testing is fueling significant investment in the sector. Clinical laboratories and life science firms are deploying automated systems to bolster research, development, and manufacturing capacities without a corresponding rise in operational expenses, often by modernizing legacy workflows to meet global healthcare demands. For instance, Thermo Fisher Scientific announced in April 2025 a commitment to invest $2 billion over four years to upgrade its U.S. manufacturing and lab services. This industry-wide trend is further corroborated by the International Federation of Robotics, which reported in 2025 that sales of medical robots rose by 91% to roughly 16,700 units during the previous year.
Market Challenge
A major obstacle impeding the Global Laboratory Robotics Market is the substantial upfront capital investment necessary for implementation. Acquiring advanced automated systems, such as robotic arms and liquid handling platforms, requires significant financial outlay that frequently surpasses the budgets of academic startups, independent clinical labs, and smaller research institutions. This economic disparity results in a polarized market where only well-funded pharmaceutical companies can fully utilize automation, compelling smaller organizations to depend on manual processes, a challenge further complicated by the costs and technical expertise needed to integrate these complex units into legacy infrastructure.
The severity of this financial barrier is reflected in the increasing adoption of alternative financing models designed to reduce capital expenditure. In 2024, the International Federation of Robotics reported a 31% increase in the global fleet of professional service robots functioning under Robot-as-a-Service (RaaS) agreements. This rise in subscription-based and leasing deployments suggests that a substantial segment of the automation market is restricting capital spending due to budget constraints, meaning that while the operational need for efficiency remains strong, traditional procurement models continue to limit broader adoption among fiscally restricted tiers of the industry.
Market Trends
The incorporation of Artificial Intelligence for Predictive Workflows is transforming laboratory operations by shifting systems from passive execution to proactive optimization. Instead of merely automating repetitive tasks like plate movements or liquid handling, advanced algorithms now assess experimental parameters in real-time to anticipate instrument failures, identify data anomalies, and optimize assay scheduling before workflows conclude. This move toward data-driven, intelligent ecosystems enables facilities to reduce expensive reagent waste and hasten discovery timelines; according to the Pistoia Alliance's 'Lab of the Future 2024 Global Survey' from September 2024, 68% of life science professionals now utilize Artificial Intelligence and Machine Learning, reflecting a significant year-over-year increase as labs prioritize data readiness.
Concurrently, the expansion of automated solutions into Next-Generation Sequencing and genomics is stimulating significant market activity as laboratories tackle the complex demands of precision medicine. Automating these sensitive genomic workflows necessitates robots with extreme precision to handle micro-volumes of costly biological samples and prevent cross-contamination, a requirement traditional industrial automation could not fulfill. This has led to a surge in orders for specialized biomedical robotic systems, a trend highlighted by the Association for Advancing Automation in February 2025; their report noted that robot orders from the pharmaceutical, life sciences, and biomedical sectors rose by 46% in 2024, outpacing traditional industrial segments.
Report Scope
In this report, the Global Laboratory Robotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Laboratory Robotics Market.
Global Laboratory Robotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: